LZTS3: A Potential Drug Target and Biomarker for Leucine Zipper Tumor Suppressor Family Member 3

Target Name: LZTS3

NCBI ID: G9762

LZTS3

LZTS3: A Potential Drug Target and Biomarker for Leucine Zipper Tumor Suppressor Family Member 3

Leucine zipper tumor suppressor family member 3 (LZTS3) is a non-coding RNA molecule that plays a crucial role in the regulation of cell growth and differentiation. LZTS3 is a part of the TGF-β complex, which is a well-known regulator of cell growth and development. The TGF-β complex is composed of several subunits, including LZTS3, which are involved in the regulation of cell proliferation, differentiation, and survival.

LZTS3 is a 24.1 kb RNA molecule that contains 16 unique amino acid residues. It is expressed in a variety of tissues, including brain, heart, liver, and pancreas. LZTS3 has been shown to play a role in the regulation of cell growth and differentiation by controlling the expression of target genes.

One of the key functions of LZTS3 is its ability to suppress the activity of the TGF-β complex. The TGF-β complex is a complex that consists of several subunits, including the TGF-β receptor, which is involved in the regulation of cell growth and differentiation. LZTS3 has been shown to interact with the TGF-β receptor and prevent it from activating. This interaction between LZTS3 and the TGF-β receptor suggests that LZTS3 may be a potential drug target for the treatment of TGF-β-related diseases.

In addition to its role in the regulation of the TGF-β complex, LZTS3 has also been shown to play a role in the regulation of cell apoptosis (programmed cell death). Apoptosis is a natural process that occurs in the cell cycle and is regulated by a variety of factors, including the TGF-β complex. LZTS3 has been shown to play a role in the regulation of cell apoptosis by controlling the expression of genes that are involved in cell death.

The role of LZTS3 in the regulation of cell apoptosis is further confirmed by its ability to induce cell apoptosis in cell culture models. In addition to its role in the regulation of cell apoptosis, LZTS3 has also been shown to play a role in the regulation of cell cycle progression. The TGF-β complex is involved in the regulation of cell cycle progression, and LZTS3 has been shown to play a role in the regulation of the G1 phase of the cell cycle.

In conclusion, LZTS3 is a non-coding RNA molecule that plays a crucial role in the regulation of cell growth and differentiation. Its ability to suppress the activity of the TGF-β complex and its role in the regulation of cell apoptosis and cell cycle progression suggest that LZTS3 may be a potential drug target for the treatment of TGF-β-related diseases. Further research is needed to fully understand the role of LZTS3 in the regulation of cell growth and development.

Protein Name: Leucine Zipper Tumor Suppressor Family Member 3

Functions: May be involved in promoting the maturation of dendritic spines, probably via regulating SIPA1L1 levels at the postsynaptic density of synapses

The "LZTS3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LZTS3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets